Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic
antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and …
antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and …
Highlights on US FDA-approved fluorinated drugs over the past five years (2018–2022)
The objective of this review is to provide an update on the fluorine-containing drugs
approved by US Food and Drug Administration in the span of past five years (2018–2022) …
approved by US Food and Drug Administration in the span of past five years (2018–2022) …
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis
PC Grayson, C Ponte, R Suppiah… - Arthritis & …, 2022 - Wiley Online Library
Objective To develop and validate revised classification criteria for eosinophilic
granulomatosis with polyangiitis (EGPA). Methods Patients with vasculitis or comparator …
granulomatosis with polyangiitis (EGPA). Methods Patients with vasculitis or comparator …
Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic
granulomatosis with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the …
granulomatosis with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the …
Eosinophils from physiology to disease: a comprehensive review
Despite being the second least represented granulocyte subpopulation in the circulating
blood, eosinophils are receiving a growing interest from the scientific community, due to their …
blood, eosinophils are receiving a growing interest from the scientific community, due to their …
Eosinophilic myocarditis: characteristics, treatment, and outcomes
M Brambatti, MV Matassini, ED Adler, K Klingel… - Journal of the American …, 2017 - jacc.org
Background: Eosinophilic myocarditis (EM) is an acute life-threatening inflammatory disease
of the heart. Neither large case series nor clinical trials on this specific myocarditis have …
of the heart. Neither large case series nor clinical trials on this specific myocarditis have …
Update on eosinophilic granulomatosis with polyangiitis
S Furuta, T Iwamoto, H Nakajima - Allergology International, 2019 - jstage.jst.go.jp
abstract Eosinophilic granulomatosis with polyangiitis (EGPA)(formerly Churg-Strauss
syndrome) is a rare form of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis …
syndrome) is a rare form of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis …
Co‐morbidities in severe asthma: C linical impact and management
C Porsbjerg, A Menzies‐Gow - Respirology, 2017 - Wiley Online Library
Patients with severe asthma represent a minority of the total asthma population, but carry a
majority of the morbidity and healthcare costs. Achieving better asthma control in this group …
majority of the morbidity and healthcare costs. Achieving better asthma control in this group …
ANCA-associated vasculitis—clinical utility of using ANCA specificity to classify patients
D Cornec, ECL Gall, FC Fervenza… - Nature Reviews …, 2016 - nature.com
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a
heterogeneous group of rare syndromes characterized by necrotizing inflammation of small …
heterogeneous group of rare syndromes characterized by necrotizing inflammation of small …
The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort
Abstract The 1996 Five-Factor Score (FFS) for systemic necrotizing vasculitides (polyarteritis
nodosa [PAN], microscopic polyangiitis [MPA], and Churg-Strauss syndrome [CSS]) is used …
nodosa [PAN], microscopic polyangiitis [MPA], and Churg-Strauss syndrome [CSS]) is used …